Journal of Personalized Medicine

Journal of Personalized Medicine
期刊缩写:
J PERS MED
影响因子:
3
ISSN:
print: 2075-4426
研究领域:
Medicine-Medicine (miscellaneous)
Gold OA文章占比:
99.66%
原创研究文献占比:
77.29%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
4.10.7360.742
学科
排名
百分位
大类:Medicine
小类:Medicine (miscellaneous)
137 / 398
65%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
3区 医学
3区 医学:内科 MEDICINE, GENERAL & INTERNAL
4区 卫生保健与服务 HEALTH CARE SCIENCES & SERVICES
WOS期刊分区
学科分类
Q2HEALTH CARE SCIENCES & SERVICES
Q1MEDICINE, GENERAL & INTERNAL
历年影响因子
2023年3.0000
历年发表
2012年21
2013年19
2014年28
2015年34
2016年20
2017年22
2018年44
2019年54
2020年327
2021年1384
2022年1878
投稿信息
出版语言:
English
出版国家(地区):
SWITZERLAND
审稿时长:
11 weeks
论文处理费:
Free
出版商:
Multidisciplinary Digital Publishing Institute (MDPI)
编辑部地址:
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052

Journal of Personalized Medicine - 最新文献

Associations of Amino Acids with the Risk of Prediabetes: A Case-Control Study from Kazakhstan.

Pub Date : 2024-10-21 DOI: 10.3390/jpm14101067 Alma Nurtazina, Ivan Voitsekhovskiy, Bakyt Kanapiyanov, Maxat Toishimanov, Daulet Dautov, Kairat Karibayev, Yerbol Smail, Dana Kozhakhmetova, Altay Dyussupov

Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study.

Pub Date : 2024-10-18 DOI: 10.3390/jpm14101066 Ji-Eun Na, Yong-Eun Park, Jong-Ha Park, Tae-Oh Kim, Jong-Yoon Lee, Jong-Hoon Lee, Su-Bum Park, Seung-Bum Lee, Seung-Min Hong

Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic Fibrosis.

Pub Date : 2024-10-17 DOI: 10.3390/jpm14101065 Susanne Naehrig, Christina Shad, Magdalena Breuling, Melanie Goetschke, Katharina Habler, Sarah Sieber, Johanna Kastenberger, Alexandra Katharina Kunzelmann, Olaf Sommerburg, Uwe Liebchen, Juergen Behr, Michael Vogeser, Michael Paal
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信